Sustained aryl hydrocarbon receptor activity attenuates liver regeneration
- PMID: 16636136
- DOI: 10.1124/mol.106.023465
Sustained aryl hydrocarbon receptor activity attenuates liver regeneration
Abstract
In hepatocyte-derived cell lines, either loss of aryl hydrocarbon receptor (AhR) function or treatment with a persistent AhR agonist such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) can disrupt G1 phase cell cycle progression. The present study used liver regeneration to explore mechanistically how AhR activity modulates hepatocyte proliferation in vivo. Treatment of mice with 20 mug/kg TCDD 1 day before 70% partial hepatectomy (PH) resulted in a 50 to 75% suppression in liver regeneration. Impaired proliferation was not associated with changes in levels of interleukin-6 or tumor necrosis factor-alpha, which prime quiescent hepatocytes to enter G1 phase. In fact, administration of TCDD 12 h after PH, a period well beyond the priming phase, still induced the G1 arrest. Decreased proliferation in TCDD-treated mice correlated with reduced cyclin-dependent kinase-2 (CDK2) activity, a pivotal regulator of G1/S phase transition. In contrast to observations made in cell culture, suppressed CDK2 activity was not strictly associated with increased binding of the CDK2 inhibitors p21Cip1 or p27Kip1. However, TCDD decreased levels of cyclin E binding to CDK2, despite normal cyclin E expression. The evidence also suggests that TCDD-induced hepatic growth arrest depends upon sustained AhR activity because transient AhR activation in response to endogenous queues failed to suppress the regenerative response. These findings establish a functional role for the AhR in regulating normal cell cycle control during liver regeneration.
Similar articles
-
Ah receptor-mediated suppression of liver regeneration through NC-XRE-driven p21Cip1 expression.Mol Pharmacol. 2014 Apr;85(4):533-41. doi: 10.1124/mol.113.089730. Epub 2014 Jan 15. Mol Pharmacol. 2014. PMID: 24431146 Free PMC article.
-
Consequences of TCDD treatment on intra-hepatic lymphocytes during liver regeneration.J Immunotoxicol. 2012 Oct-Dec;9(4):359-67. doi: 10.3109/1547691X.2012.664577. Epub 2012 Apr 24. J Immunotoxicol. 2012. PMID: 22530936
-
The activated aryl hydrocarbon receptor synergizes mitogen-induced murine liver hyperplasia.Toxicology. 2010 Oct 9;276(2):103-9. doi: 10.1016/j.tox.2010.07.004. Epub 2010 Jul 14. Toxicology. 2010. PMID: 20637255 Free PMC article.
-
Activation of the aryl hydrocarbon receptor by TCDD inhibits senescence: a tumor promoting event?Biochem Pharmacol. 2009 Feb 15;77(4):681-8. doi: 10.1016/j.bcp.2008.11.022. Epub 2008 Nov 27. Biochem Pharmacol. 2009. PMID: 19100242 Free PMC article. Review.
-
Ah receptor- and TCDD-mediated liver tumor promotion: clonal selection and expansion of cells evading growth arrest and apoptosis.Biochem Pharmacol. 2005 May 15;69(10):1403-8. doi: 10.1016/j.bcp.2005.02.004. Biochem Pharmacol. 2005. PMID: 15857604 Review.
Cited by
-
From Nucleus to Organs: Insights of Aryl Hydrocarbon Receptor Molecular Mechanisms.Int J Mol Sci. 2022 Nov 29;23(23):14919. doi: 10.3390/ijms232314919. Int J Mol Sci. 2022. PMID: 36499247 Free PMC article. Review.
-
Cinnabarinic Acid Provides Hepatoprotection Against Nonalcoholic Fatty Liver Disease.J Pharmacol Exp Ther. 2022 Oct;383(1):32-43. doi: 10.1124/jpet.122.001301. Epub 2022 Aug 6. J Pharmacol Exp Ther. 2022. PMID: 35933113 Free PMC article.
-
Aryl hydrocarbon receptor blocks aging-induced senescence in the liver and fibroblast cells.Aging (Albany NY). 2022 May 26;14(10):4281-4304. doi: 10.18632/aging.204103. Epub 2022 May 26. Aging (Albany NY). 2022. PMID: 35619220 Free PMC article.
-
Aryl Hydrocarbon Receptor: From Homeostasis to Tumor Progression.Front Cell Dev Biol. 2022 Apr 7;10:884004. doi: 10.3389/fcell.2022.884004. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35465323 Free PMC article. Review.
-
Proteomics Indicates Lactate Dehydrogenase Is Prognostic in Acetaminophen-Induced Acute Liver Failure Patients and Reveals Altered Signaling Pathways.Toxicol Sci. 2022 Apr 26;187(1):25-34. doi: 10.1093/toxsci/kfac015. Toxicol Sci. 2022. PMID: 35172013 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources